R E S E A R C H N E W S
As COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. The California-based UC-NL ATTACK Consortium is building on our novel science and technologies towards drug discovery. Hear more from the recent ATTACK Consortium conference.
Our UCLA campus lead Professor Robert Damoiseaux in collaboration with Vaithilingaraja Arumugaswami and his research team discovered compounds that could treat COVID-19. This work was published in the journal Cell Reports and highlighted in a Pharmafile article.
UC-NL ATTACK Consortium E V E N T S
The UC-NL ATTACK Consortium and its participating campuses and organizations are planning a wide array of antiviral drug discovery-related symposia, seminars, and other events that are open to faculty, staff, and trainees